Literature DB >> 21439805

Toll-like receptor expression in smokers with and without COPD.

Ida von Scheele1, Kjell Larsson, Barbro Dahlén, Bo Billing, Maria Skedinger, Ann-Sofie Lantz, Lena Palmberg.   

Abstract

INTRODUCTION: Chronic obstructive pulmonary disease (COPD) is characterized by non-reversible airflow limitation and systemic engagement. Bacterial colonization in the lungs is common in COPD-patients and may be associated with frequent acute exacerbations. Pattern-recognition receptors (PRRs), like Toll-like receptor 2 (TLR2), TLR4 and CD14 are expressed on most immunologic active cell types and are most likely of importance in COPD patho-physiology.
MATERIAL AND METHODS: Twenty smokers with and 20 without COPD and 20 healthy non-smokers participated in the study. At two visits, induced sputum was collected after spirometry, blood was sampled and bronchoscopy with bronchoalveolar lavage was performed. Expression of TLR2, TLR4 and CD14 on different cell types and soluble receptors were assessed in the different compartments.
RESULTS: Expression of TLR2 was lower on sputum neutrophils and soluble TLR2 (sTLR2) was higher in the supernatant in the COPD group, indicating a down regulation of TLR2 at the transit from blood to sputum. Expression of CD14 on sputum neutrophils and gene expression of CD14 on alveolar macrophages was up-regulated in the two smoking groups compared with non-smokers. No differences between the groups were found regarding TLR4 expression.
CONCLUSIONS: Pattern-recognition receptors (PRRs), that are expected to make a first line of defense against invading micro-organisms, are differently regulated in smokers with COPD compared with smokers without airflow limitation and non-smokers. This is likely of importance in COPD patho-physiology, in particular for exacerbations, which often are caused by micro-organisms.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21439805     DOI: 10.1016/j.rmed.2011.02.012

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  20 in total

Review 1.  The role of Toll-like receptors in age-associated lung diseases.

Authors:  Maria Volkova; Yitao Zhang; Albert C Shaw; Patty J Lee
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2012-03-05       Impact factor: 6.053

2.  A mammalian Wnt5a-Ror2-Vangl2 axis controls the cytoskeleton and confers cellular properties required for alveologenesis.

Authors:  Kuan Zhang; Erica Yao; Chuwen Lin; Yu-Ting Chou; Julia Wong; Jianying Li; Paul J Wolters; Pao-Tien Chuang
Journal:  Elife       Date:  2020-05-12       Impact factor: 8.140

3.  Inhaled corticosteroid suppression of cathelicidin drives dysbiosis and bacterial infection in chronic obstructive pulmonary disease.

Authors:  Aran Singanayagam; Nicholas Glanville; Leah Cuthbertson; Nathan W Bartlett; Lydia J Finney; Elena Turek; Eteri Bakhsoliani; Maria Adelaide Calderazzo; Maria-Belen Trujillo-Torralbo; Joseph Footitt; Phillip L James; Peter Fenwick; Samuel V Kemp; Thomas B Clarke; Jadwiga A Wedzicha; Michael R Edwards; Miriam Moffatt; William O Cookson; Patrick Mallia; Sebastian L Johnston
Journal:  Sci Transl Med       Date:  2019-08-28       Impact factor: 17.956

4.  Influence of age, past smoking, and disease severity on TLR2, neutrophilic inflammation, and MMP-9 levels in COPD.

Authors:  Jodie L Simpson; Vanessa M McDonald; Katherine J Baines; Kevin M Oreo; Fang Wang; Philip M Hansbro; Peter G Gibson
Journal:  Mediators Inflamm       Date:  2013-03-31       Impact factor: 4.711

5.  Tumour cell derived effects on monocyte/macrophage polarization and function and modulatory potential of Viscum album lipophilic extract in vitro.

Authors:  Myriam Estko; Stephan Baumgartner; Konrad Urech; Matthias Kunz; Ursula Regueiro; Peter Heusser; Ulrike Weissenstein
Journal:  BMC Complement Altern Med       Date:  2015-04-24       Impact factor: 3.659

6.  Toll-like receptor 2 and 4 have opposing roles in the pathogenesis of cigarette smoke-induced chronic obstructive pulmonary disease.

Authors:  Tatt Jhong Haw; Malcolm R Starkey; Stelios Pavlidis; Michael Fricker; Anya L Arthurs; Prema M Nair; Gang Liu; Irwan Hanish; Richard Y Kim; Paul S Foster; Jay C Horvat; Ian M Adcock; Philip M Hansbro
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2017-10-12       Impact factor: 5.464

7.  Toll-like receptor (TLR2 and TLR4) polymorphisms and chronic obstructive pulmonary disease.

Authors:  Simona E Budulac; H Marike Boezen; Pieter S Hiemstra; Therese S Lapperre; Judith M Vonk; Wim Timens; Dirkje S Postma
Journal:  PLoS One       Date:  2012-08-28       Impact factor: 3.240

8.  The association of down-regulated toll-like receptor 4 expression with airflow limitation and emphysema in smokers.

Authors:  Sei Won Lee; Dal Rae Kim; Tae Jung Kim; Jin Ho Paik; Jin-Haeng Chung; Sanghoon Jheon; Jin Won Huh; Jae-Ho Lee; Choon-Taek Lee
Journal:  Respir Res       Date:  2012-11-21

Review 9.  Lung microbiology and exacerbations in COPD.

Authors:  Victoria Beasley; Priya V Joshi; Aran Singanayagam; Philip L Molyneaux; Sebastian L Johnston; Patrick Mallia
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2012-08-31

10.  Interactions between alveolar epithelial cells and neutrophils under pro-inflammatory conditions.

Authors:  Ida von Schéele; Kjell Larsson; Lena Palmberg
Journal:  Eur Clin Respir J       Date:  2014-09-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.